<DOC>
	<DOCNO>NCT02967120</DOCNO>
	<brief_summary>The purpose study verify function p16 hydroxymethylation diagnostic reagent early diagnosis oral cancer .</brief_summary>
	<brief_title>Early Diagnosis Oral Cancer Detecting p16 Hydroxymethylation</brief_title>
	<detailed_description>Background : Oral epithelial dysplasia ( OED ) one common precancerous lesion among Chinese adult . To investigate clinical predictive value p16 hydroxymethylation diagnostic reagent early diagnosis oral cancer , investigator carry prospective multi-center double-blind cohort study . Methods:336 patient histologically confirm mild moderate OED include present study . After bisulfite modification tet assistant bisulfite modification , MethyLight Methylation-specific PCR ( MSP ) assay use analyze p16 methylation status patient . Building three follow-up queue p16-methylated , p16-hydroxymethylation p16-unmethylated . The Statistical analysis use SPSS16.0 . All P-values two-sided . P &lt; 0.05 consider test statistical significance difference .</detailed_description>
	<mesh_term>Carcinoma Situ</mesh_term>
	<criteria>Histopathological diagnosis oral lesion meet epithelial diagnostic criterion mild moderate grade OED ; No local area stimulate residual root crown , sharp cusp , poor restoration bite cheek lip ; Without treatment history laser , radiation chemical ; Be able Sign inform consent ; Histopathological diagnosis oral lesion meet epithelium mild moderate dysplasia diagnostic criterion ; histological diagnosis severe grade OED malignant disease ; Pregnancy breastfeed woman ; Serious heart , lung , liver , kidney systemic disease local area stimulate residual root crown , sharp cusp , poor restoration bite cheek lip ; OED treatment history LASER , radiotherapy , chemotherapy ; Tumor psychiatric patient ; Patients unable cooperate ;</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>